Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Stock Exchange of Hong Kong  >  Sinopharm Group Co. Ltd.    1099   CNE100000FN7

SINOPHARM GROUP CO. LTD.

(1099)
  Report  
End-of-day quote. End-of-day quote Stock Exchange of Hong Kong - 12/06
26.4 HKD   +0.38%
12/04China stocks rise on Trump's remarks on trade talks; Hang Seng gains
RE
11/15SINOPHARM GROUP CO. LTD. : A technical turn-around configuration
10/27SINOPHARM : Nine-Month Net Profit Rose 12%
DJ
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Stock Exchange Of Hong Ko…
12/02/2019 12/03/2019 12/04/2019 12/05/2019 12/06/2019 Date
25.85 25.95 25.9 26.3 26.4 Last
2971438 4526020 4231449 5850319 4706216 Volume
0.00% +0.39% -0.19% +1.54% +0.38% Change
Financials (CNY)
Sales 2019 413 B
EBIT 2019 17 447 M
Net income 2019 6 427 M
Debt 2019 30 247 M
Yield 2019 2,67%
Sales 2020 469 B
EBIT 2020 19 692 M
Net income 2020 7 307 M
Debt 2020 20 712 M
Yield 2020 3,03%
P/E ratio 2019 10,9x
P/E ratio 2020 9,60x
EV / Sales2019 0,24x
EV / Sales2020 0,19x
Capitalization 70 272 M
More Financials
Company
Sinopharm Group Company Limited is principally engaged in the distribution of pharmaceutical products and medical equipment. The Company operates through three business segments. The Pharmaceutical Distribution segment is engaged in the distribution of medicines, medicine devices and pharmaceutical... 
Sector
Drug Retailers
Calendar
03/20Earnings Release
More about the company
Surperformance© ratings of Sinopharm Group Co. Ltd.
Trading Rating : Investor Rating :
More Ratings
Latest news on SINOPHARM GROUP CO. LTD.
12/04China stocks rise on Trump's remarks on trade talks; Hang Seng gains
RE
10/27SINOPHARM : Nine-Month Net Profit Rose 12%
DJ
10/27SINOPHARM : Announcement
PU
10/25SINOPHARM : Announcement principal financial data of cnmdc for the nine months e..
PU
10/23SINOPHARM : Announcement principal financial data of sinopharm (cncm ltd) for th..
PU
10/23SINOPHARM : Announcement principal financial data of sinopharm accord for the ni..
PU
09/18SINOPHARM : Notification Letter with Request Form to Non-Registered Shareholders
PU
09/18SINOPHARM : Notification Letter with Request Form to Registered Shareholders
PU
07/02SINOPHARM HOLDING CO LTD : Ex-dividend day for final dividend
FA
04/08SINOPHARM : Announcements and Notices - Notice of Board Meeting
PU
03/24SINOPHARM : year net up 4.7% to RMB5.84 billion
AQ
2018SINOPHARM HOLDING CO LTD : Ex-dividend day for final dividend
FA
2018SINOPHARM : Announcements and Notices - Announcement Poll Results of the Annual ..
PU
2018SINOPHARM : Announcements and Notices - Announcement Principal Financial Data of..
PU
2018SINOPHARM : Announcements and Notices - Proposed Amendments to the Articles of A..
PU
More news
News in other languages on SINOPHARM GROUP CO. LTD.
07/02SINOPHARM HOLDING CO LTD : Ex-dividend day for final dividend
03/22EN DIRECT DES MARCHES : Vivendi, Sequana, Eiffage, Facebook, Swedbank, Alcon,..
03/22STOCK MARKET PARIS : La tech US se rebiffe, dernière cartouche pour May
2018SINOPHARM HOLDING CO LTD : Ex-dividend day for final dividend
2016SINOPHARM HOLDING CO LTD : publication des résultats semestriels
More news
Analyst Recommendations on SINOPHARM GROUP CO. LTD.
More recommendations
Stock Trading Strategies
SINOPHARM GROUP CO. LTD. - 11/15
A technical turn-around configuration
BUY
More Stock Trading Analysis
Sector news : Drug Retailers - NEC
12/05SUNDAR PICHAI : Alphabet's 'Other bets' in focus as Google's Pichai takes helm
RE
12/03Pharmacy chains sue Bausch Health, other drugmakers for overcharging for diab..
RE
12/02Southeast Asian startup FinAccel raises $90 million to build digital credit c..
RE
12/02Buyout Activity Declines Sharply -- WSJ
DJ
12/01Private-Equity Cash Piles Up as Takeover Targets Get Pricier
DJ
More sector news : Drug Retailers - NEC
Chart SINOPHARM GROUP CO. LTD.
Duration : Period :
Sinopharm Group Co. Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SINOPHARM GROUP CO. LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 20
Average target price 31,71  CNY
Last Close Price 23,68  CNY
Spread / Highest target 60,7%
Spread / Average Target 33,9%
Spread / Lowest Target 4,66%
EPS Revisions
Managers
NameTitle
Yong Liu President & Executive Director
Fang Yao Chairman-Supervisory Board
Zhi Ming Li Chairman
Xiu Chang Jiang Chief Financial Officer & Vice President
Jin Dong Deng Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
SINOPHARM GROUP CO. LTD.-19.76%9 969
WALGREENS BOOTS ALLIANCE-13.51%52 749
MCKESSON CORPORATION27.28%25 336
CARDINAL HEALTH, INC.21.64%15 867
WELCIA HOLDINGS CO., LTD.35.98%6 481
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD3.76%6 468